| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A8K8K7 | cDNA FLJ77461, highly similar to Homo sapiens suppression of tumorigenicity 7 (ST7), transcript variant a, mRNA; | NULL | NULL | 554 | human |
| Q53GR6 | SH3 domain and tetratricopeptide repeats 1 variant; Fragment; | NULL | NULL | 1195 | human |
| Q7Z3B7 | Putative uncharacterized protein DKFZp451N061; Fragment; | DKFZp451N061; | NP_596870.2; | 1263 | human |
| B2R9I9 | cDNA, FLJ94417, highly similar to Homo sapiens WD repeat domain 57 (U5 snRNP specific) (WDR57), mRNA; | NULL | NULL | 357 | human |
| B0FYA9 | Neuregulin 1 isoform ndf43-beta2; Fragment; | NRG1; | NP_001153476.1; | 458 | human |
| A9XAI1 | Alpha-helix coiled-coil rod homologue; Fragment; | HCR; | NULL | 42 | human |
| E5RG38 | LYR motif-containing protein 2; | LYRM2; | NULL | 77 | human |
| A9QQ14 | Actin nucleation promoting factor; Fragment; | WASH; | NULL | 407 | human |
| B2R4X4 | cDNA, FLJ92255, highly similar to Homo sapiens ring finger protein 7 (RNF7), mRNA; | NULL | NULL | 113 | human |
| A7ISW3 | UDP-glucuronosyltransferase 1A3; Fragment; | UGT1A3; | NULL | 289 | human |
| A8K2X4 | cDNA FLJ75401, highly similar to Homo sapiens endoglin (Osler-Rendu-Weber syndrome 1), mRNA; | NULL | NULL | 658 | human |
| Q08GE1 | Rhesus blood group, D antigen; | RHD; | NULL | 417 | human |
| B2RA77 | cDNA, FLJ94743, highly similar to Homo sapiens oviductal glycoprotein 1, 120kDa (mucin 9, oviductin) (OVGP1), mRNA; | NULL | NULL | 678 | human |
| B2R8Q2 | Sulfotransferase; EC 2.8.2.-; | NULL | NULL | 367 | human |
| B2R577 | Protein S100; S100 calcium-binding protein; | NULL | NULL | 90 | human |
| Q6ZV49 | cDNA FLJ42988 fis, clone BRTHA2008955; | NULL | NULL | 322 | human |
| A2N0T8 | VH6DJ protein; Fragment; | VH6DJ; | NULL | 116 | human |
| B3KMH8 | Autophagy protein 5; | NULL | NULL | 275 | human |
| B2RDE1 | cDNA, FLJ96568, highly similar to Homo sapiens tropomyosin 3 (TPM3), mRNA; | NULL | NULL | 248 | human |
| B2NJ33 | MHC Class II antigen; Fragment; | HLA-DRB1; | NULL | 89 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |